{
  "trial_id": "NCT02316249",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Informed Consent Form",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Recruitment via direct contact from patient population",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Randomization to use estrogen cream or placebo",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Participants will be provided with medication in prepackaged syringes",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Study participants will return for follow-up appointments at 2 weeks, 6 weeks, 12 weeks and 6 months",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Vaginal culture will be obtained at any visit if the patient complains of a bothersome, malodorous discharge",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Questionnaires will be completed at baseline, 12 week and 6 month",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Participant reports not using the cream or returning syringes unused",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Participant develops or has a new diagnosis of any conditions that are reactions/adverse events occur from the use of Estrace or placebo",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "Patient is a 16-year-old girl recently diagnosed with myasthenia gravis. She has diplopia and weakness affecting her upper extremities, but she does not smoke or use illicit drugs.",
  "_meta": {
    "topic_id": "72",
    "trial_id": "NCT02316249",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}